L. Tong

8.7k total citations
27 papers, 1.2k citations indexed

About

L. Tong is a scholar working on Molecular Biology, Epidemiology and Infectious Diseases. According to data from OpenAlex, L. Tong has authored 27 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 10 papers in Epidemiology and 6 papers in Infectious Diseases. Recurrent topics in L. Tong's work include Hepatitis C virus research (5 papers), interferon and immune responses (4 papers) and Herpesvirus Infections and Treatments (4 papers). L. Tong is often cited by papers focused on Hepatitis C virus research (5 papers), interferon and immune responses (4 papers) and Herpesvirus Infections and Treatments (4 papers). L. Tong collaborates with scholars based in United Kingdom, United States and China. L. Tong's co-authors include Nikola P. Pavletich, Philip D. Jeffrey, Alicia A. Russo, Jie‐Oh Lee, Joel F. Moxley, Gregory Stephanopoulos, Jason L. Walther, Kyle Jensen, Mark P. Styczynski and Chris Boutell and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Genes & Development.

In The Last Decade

L. Tong

27 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L. Tong United Kingdom 15 790 415 199 137 95 27 1.2k
Carolyn J.M. Best United States 14 827 1.0× 189 0.5× 101 0.5× 103 0.8× 68 0.7× 18 1.3k
Oliver Drews Germany 21 915 1.2× 200 0.5× 215 1.1× 217 1.6× 151 1.6× 43 1.4k
Jyoti Sharma India 19 663 0.8× 129 0.3× 140 0.7× 62 0.5× 147 1.5× 64 1.2k
Sylvie Bourassa Canada 24 1.4k 1.7× 611 1.5× 161 0.8× 191 1.4× 251 2.6× 45 2.1k
Maria Hernandez-Valladares Norway 21 688 0.9× 121 0.3× 197 1.0× 183 1.3× 144 1.5× 59 1.5k
Sneha M. Pinto India 23 878 1.1× 191 0.5× 164 0.8× 86 0.6× 292 3.1× 76 1.7k
S. Rajagopalan United States 20 1.1k 1.3× 381 0.9× 96 0.5× 74 0.5× 44 0.5× 33 1.4k
Fernando Lopitz‐Otsoa Spain 22 1.2k 1.5× 406 1.0× 364 1.8× 140 1.0× 225 2.4× 44 1.7k
Joshua L. Andersen United States 20 784 1.0× 144 0.3× 260 1.3× 133 1.0× 196 2.1× 32 1.3k
Ming‐Yi Ho Taiwan 18 541 0.7× 120 0.3× 158 0.8× 77 0.6× 196 2.1× 28 976

Countries citing papers authored by L. Tong

Since Specialization
Citations

This map shows the geographic impact of L. Tong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Tong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Tong more than expected).

Fields of papers citing papers by L. Tong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Tong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Tong. The network helps show where L. Tong may publish in the future.

Co-authorship network of co-authors of L. Tong

This figure shows the co-authorship network connecting the top 25 collaborators of L. Tong. A scholar is included among the top collaborators of L. Tong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Tong. L. Tong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fang, Jing, et al.. (2024). RGX Ensemble Model for Advanced Prediction of Mortality Outcomes in Stroke Patients. SHILAP Revista de lepidopterología. 5. 77–77. 1 indexed citations
2.
Martinez, Julien, Perran A. Ross, Xinyue Gu, et al.. (2022). Genomic and Phenotypic Comparisons Reveal Distinct Variants of Wolbachia Strain w AlbB. Applied and Environmental Microbiology. 88(22). e0141222–e0141222. 5 indexed citations
3.
Shah, Rajiv, Stephen T. Barclay, Ray Fox, et al.. (2022). Characterisation of a Hepatitis C Virus Subtype 2a Cluster in Scottish PWID with a Suboptimal Response to Glecaprevir/Pibrentasvir Treatment. Viruses. 14(8). 1678–1678. 1 indexed citations
4.
Sugrue, Elena, Arthur Wickenhagen, Nardus Mollentze, et al.. (2022). The apparent interferon resistance of transmitted HIV-1 is possibly a consequence of enhanced replicative fitness. PLoS Pathogens. 18(11). e1010973–e1010973. 3 indexed citations
5.
Martinez, Julien, et al.. (2022). Genome sequencing and comparative analysis of Wolbachia strain wAlbA reveals Wolbachia-associated plasmids are common. PLoS Genetics. 18(9). e1010406–e1010406. 12 indexed citations
6.
Xu, Ru, Elihú Aranday-Cortés, E. Carol McWilliam Leitch, et al.. (2022). The evolutionary dynamics and epidemiological history of hepatitis C virus genotype 6, including unique strains from the Li community of Hainan Island, China. Virus Evolution. 8(1). veac012–veac012. 2 indexed citations
8.
Singer, Joshua B., Emma C. Thomson, Joseph Hughes, et al.. (2019). Interpreting Viral Deep Sequencing Data with GLUE. Viruses. 11(4). 323–323. 17 indexed citations
9.
Modha, Sejal, Joseph Hughes, Heather M. Ferguson, et al.. (2019). Metaviromics Reveals Unknown Viral Diversity in the Biting Midge Culicoides impunctatus. Viruses. 11(9). 865–865. 15 indexed citations
10.
Childs, Kate, Christopher Davis, Mary Cannon, et al.. (2019). Suboptimal SVR rates in African patients with atypical genotype 1 subtypes: Implications for global elimination of hepatitis C. Journal of Hepatology. 71(6). 1099–1105. 42 indexed citations
11.
Dunlop, James I., Agnieszka M. Szemiel, Aitor Navarro, et al.. (2018). Development of reverse genetics systems and investigation of host response antagonism and reassortment potential for Cache Valley and Kairi viruses, two emerging orthobunyaviruses of the Americas. PLoS neglected tropical diseases. 12(10). e0006884–e0006884. 14 indexed citations
12.
Shih, Kendrick Co, et al.. (2018). Prevalence and severity of smartphone addiction and dry eye disease in university students. 2 indexed citations
13.
Selinger, Martin, Gavin S. Wilkie, L. Tong, et al.. (2017). Analysis of tick-borne encephalitis virus-induced host responses in human cells of neuronal origin and interferon-mediated protection. Journal of General Virology. 98(8). 2043–2060. 19 indexed citations
14.
Conn, Kristen L., Steven McFarlane, L. Tong, et al.. (2016). Novel Role for Protein Inhibitor of Activated STAT 4 (PIAS4) in the Restriction of Herpes Simplex Virus 1 by the Cellular Intrinsic Antiviral Immune Response. Journal of Virology. 90(9). 4807–4826. 32 indexed citations
16.
Moxley, Joel F., Michael C. Jewett, Maciek R. Antoniewicz, et al.. (2009). Linking high-resolution metabolic flux phenotypes and transcriptional regulation in yeast modulated by the global regulator Gcn4p. Proceedings of the National Academy of Sciences. 106(16). 6477–6482. 129 indexed citations
17.
Styczynski, Mark P., Joel F. Moxley, L. Tong, et al.. (2006). Systematic Identification of Conserved Metabolites in GC/MS Data for Metabolomics and Biomarker Discovery. Analytical Chemistry. 79(3). 966–973. 200 indexed citations
18.
Tong, L., et al.. (2003). Glycosylation Changes as Markers for the Diagnosis and Treatment of Human Disease. Biotechnology and Genetic Engineering Reviews. 20(1). 199–246. 19 indexed citations
19.
Jeffrey, Philip D., L. Tong, & Nikola P. Pavletich. (2000). Structural basis of inhibition of CDK–cyclin complexes by INK4 inhibitors. Genes & Development. 14(24). 3115–3125. 180 indexed citations
20.
Russo, Alicia A., L. Tong, Jie‐Oh Lee, Philip D. Jeffrey, & Nikola P. Pavletich. (1998). Structural basis for inhibition of the cyclin-dependent kinase Cdk6 by the tumour suppressor p16INK4a. Nature. 395(6699). 237–243. 390 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026